Name | Value |
---|---|
Revenues | 43.0M |
Cost of Revenue | 37.5M |
Gross Profit | 5.5M |
Operating Expense | 6.8M |
Operating I/L | -1.3M |
Other Income/Expense | -3.9M |
Interest Income | 0.0M |
Pretax | -5.2M |
Income Tax Expense | 117.9M |
Net Income/Loss | -123.1M |
Avid Bioservices, Inc. is a contract development and manufacturing organization specializing in biopharmaceutical drug substances derived from mammalian cell culture. The company offers process development, current good manufacturing practices (CGMP) clinical and commercial manufacturing services, including monoclonal antibodies and recombinant proteins production, purification, bulk packaging, and regulatory support. Additionally, it provides process development services such as upstream and downstream development, analytical methods development, and testing. Avid Bioservices, Inc. generates revenue by providing CGMP clinical and commercial drug substance manufacturing, purification, and related services to biotechnology and pharmaceutical companies.